Dataset Catalogue
Explore and export comprehensive AMR datasets
Economic Data in Clinical Outcomes
Combatting Antimicrobial Resistance in Uganda: A Data-Driven Approach to Optimize Antibiotic Use and Improve Patient Outcomes
Economic Data in Clinical Outcomes: A cross-sectional study examining the economic burden of antimicrobial resistance through paper-based data collection from 9 regional referral hospitals in Uganda, documenting costs and financial impacts associated with AMR infections and treatment outcomes during March 2023 to March 2024.
Antimicrobial Use Fleming II Human
Fleming Fund Country Grant II
Antimicrobial Use Fleming II Human: A surveillance study capturing antibiotic prescribing patterns and usage data from 8,992 patients across regional referral hospitals in Uganda using the WHO Point Prevalence Survey (PPS) tool, providing insights into antimicrobial consumption, demographic factors, and pharmacy practices from October 2020 to October 2023.
Clinical outcomes
Combatting Antimicrobial Resistance in Uganda: A Data-Driven Approach to Optimize Antibiotic Use and Improve Patient Outcomes
Clinical Outcomes: A cross-sectional study tracking clinical outcomes, antibiotic resistance patterns, and patient demographics for 599 hospitalized patients in regional referral hospitals, collected via REDCap as part of the CAMO-Net Uganda program to optimize antibiotic use and improve patient outcomes from March 2023 to March 2024.
AMR Fleming II Human
Fleming Fund Country Grant II
AMR Fleming II Human: A comprehensive surveillance dataset of 20,062 antimicrobial resistance records from regional referral hospitals and Mbarara University's medical microbiology department, containing microbiology culture results, antibiotic susceptibility testing, and demographic data collected through WHONET, ALIS, and Excel from October 2020 to October 2023.